Cravatex
358.00
0.00(0.00%)
Market Cap₹92.40 Cr
PE Ratio13.59
Company Performance:
1D0.00%
1M-0.18%
6M-4.33%
1Y-19.37%
5Y+20.15%
View Company Insightsright
More news about Cravatex
12Feb 26
Cravatex Limited Reports Strong Q3FY26 Results with 7.76% Growth in Net Profit
Cravatex Limited reported strong Q3FY26 financial results with standalone net profit growing 7.76% to ₹264.02 lacs and revenue from operations increasing 23.40% to ₹313.12 lacs compared to Q3FY25. On a consolidated basis, the company achieved revenue of ₹3,678.92 lacs with net profit surging 438.33% to ₹134.76 lacs. The results were approved by the Board of Directors on February 12, 2026, and demonstrate the company's robust operational performance across both standalone and consolidated metrics.
 no imag found
12Aug 25
Cravatex Limited Reports Mixed Q1 Results: Standalone Profit Amidst Consolidated Loss
Cravatex Limited announced its Q1 financial results, showing a mixed performance. Standalone operations were profitable with revenue of Rs. 144.14 lakhs and a profit of Rs. 44.21 lakhs. However, consolidated results showed a loss of Rs. 136.77 lakhs on revenue of Rs. 2,312.69 lakhs. The company's subsidiaries, BB (UK) Limited and BB Euro GmbH, contributed Rs. 2,554.16 lakhs in total income but reported a combined net loss of Rs. 180.99 lakhs. The standalone EPS was Rs. 1.71, while the consolidated EPS was negative at Rs. 5.29.
 no imag found
Cravatex
358.00
0.0
(0.0%)
1 Year Returns:-19.37%
Industry Peers
Redington
243.98
(+0.49%)
MMTC
75.74
(+7.91%)
MSTC
708.80
(+12.55%)
BN Agrochem
292.20
(+4.10%)
Ravindra Energy
142.52
(-3.01%)
TCC Concept
348.60
(+0.43%)
Creative Newtech
707.65
(-2.39%)
The Yamuna Syndicate
28,001.00
(0.0%)